Advertisement

Topics

DIAGNOSTIC ONCOLOGY CRO, Inc Company Profile

08:51 EST 21st November 2017 | BioPortfolio

DOCRO is the leading clinical research organization specializing in the design and conduct of clinical trials of in vitro diagnostic products to gain marketing clearance/approval from the U.S. Food and Drug Administration. DOCRO has demonstrated its expertise and real-world experience in the development, clinical validation, and market-making introduction of many of then new and innovative, but now standard of care, diagnostic tests in the field of oncology. DOCRO's name is a bit of a misnomer because DOCRO does provide services outside the field of tumor marker assays. DOCRO has a great deal of experience with a wide variety of protein based and molecular biology-based diagnostic tests. Beside our core specialty of oncology, DOCRO has worked extensively in infectious diseases, perinatal and prenatal disease, cardiology, endocrinology, metabolic diseases, obstetrics and gynecology, hematology/coagulation, transplant immunology, drugs of abuse, and other medical specialties

Location

73 Cogwheel Lane
Seymour
Connecticut
06483
United States of America

Contact

Phone: 203.881.1032
Fax: 203.881.1193
Email: info@docro.com


News Articles [683 Associated News Articles listed on BioPortfolio]

#jobs #lifescience AstraZeneca – Cambridge: Associate Director/Director – Diagnostic Expert Oncology

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Associate Director/Director – Diagnostic...

Another win for precision medicine: FDA approves companion diagnostic panel

After decades of research and theoretical debates, it seems precision oncology is finally falling into place, capped off with Thursday’s approval of a companion diagnostic for multiple cancer

Konica Minolta Adds Ambry Genetics As First Piece Of Precision Medicine Business

The $1bn deal, partly funded by the public/private Innovation Network Corporation of Japan, will create new diagnostic technologies for oncology...   

Immunoprotein Diagnostic Testing Market by Technology Radioimmunoassay, Immunoturbidity Assay, Chemiluminescence Assay, Immunoprotein Electrophoresis, EnzymeBased Immunoassay, and Immunofluorescence Assay, by Type C reactive Protein Diagnostic Test, Comp

Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cel...

Horizon Discovery Announces Inclusion of its Reference Standards in Successful FDA Approval of an Oncology Companion Diagnostic Test with Leading Next Generation Sequencing Company

Horizon’s reference standards supported assay development and subsequent clinical trial - Horizon is a leader in the application of cancer biomarkers in diagnostics and research Horizon Discover...

Asuragen to Present at 29th Annual Piper Jaffray Healthcare Conference

Asuragen, Inc., a global molecular diagnostics product company changing the way patients are treated in genetics and oncology by bringing complex molecular tests to hospital and r...

What is “integrative oncology”? Even the Society for Integrative Oncology doesn’t seem to know for sure

Last week, the Society for Integrative Oncology published an article attempting to define what "integrative oncology" is. The definition, when it isn't totally vague, ignores the pseudoscience at the ...

New Diagnostic Tools Unveiled at EuroMedLab Exhibition

A major international manufacturer of automated diagnostic instruments and point-of-care diagnostic products has changed its name, a change that was...

Drugs and Medications [31 Associated Drugs and Medications listed on BioPortfolio]

Neutrexin (trimetrexate glucuronate for injection) [MedImmune Oncology, Inc.]

NEUTREXIN (trimetrexate glucuronate for injection)

Fludeoxyglucose f18 [THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f 18 [Triad Isotopes, Inc.]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f 18 [Precision Nuclear LLC]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f 18 [PETNET Solutions, Inc.]

These highlights do not include all the information needed to use F ludeoxyglucose   F 18   I njection safely and effectively. See full prescribing information for F ludeoxyglucose   F

PubMed Articles [2537 Associated PubMed Articles listed on BioPortfolio]

Amino acid PET in neuro-oncology: applications in the clinic.

Since decades, common classical indications for amino acid PET in brain tumor patients are the distinction between tumor and nontumor, the delineation of tumor extent for planning of further diagnosti...

Hematology-Oncology Fellows' Training in Geriatrics and Geriatric Oncology: Findings From an American Society of Clinical Oncology-Sponsored National Survey.

Older adults compose the majority of patients with cancer in the United States; however, it is unclear how well geriatrics or geriatric oncology training is being incorporated into hematology-oncology...

Incidental detection of colorectal lesions by FDG PET/CT scans in melanoma patients.

Increased use of PET/CT scans in oncology patients has raised detection of Colorectal incidentalomas (CIs). The frequency and diagnostic outcomes of identifying these lesions in melanoma patients have...

Cardiotoxicity in oncology and coronary microcirculation: future challenges in theranostics.

Many of the patients undergoing chemotherapy or radiotherapy for cancer are at increased risk of developing cardiovascular diseases. Recent evidence suggests that cardiac dysfunction and subsequent he...

The Diagnostic Dilemma of Epithelial Marker Expression in Glioblastoma.

Clinical Trials [2155 Associated Clinical Trials listed on BioPortfolio]

Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology

The purpose of the study is to determine the diagnostic accuracy of a new magnetic resonance imaging (MRI) technique, the diffusion weighted imaging with body background signal suppression...

Communicating a Cancer Diagnosis-Current Methods and Their Effects

This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will: ...

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Companies [1633 Associated Companies listed on BioPortfolio]

DIAGNOSTIC ONCOLOGY CRO, Inc

DOCRO is the leading clinical research organization specializing in the design and conduct of clinical trials of in vitro diagnostic products to gain marketing clearance/approval from the U.S. Food an...

Clarient, Inc.

Clarient combines innovative diagnostic technologies with world class pathology expertise to assess and characterize cancer. Clarient's mission is to become the leader in cancer diagnostics by dedica...

OTraces, Inc.

OTraces (www.OTraces.net) is a biotech company based in Rockville, Md, that provides advanced oncology diagnostic systems. It has developed a protein-based method (proteomi...

ChipDX LLC

ChipDX develops and delivers novel multi-gene diagnostic and prognostic assays for oncology research use only. The aim of the company is to increase access to advanced, well-valid...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion ...

More Information about "DIAGNOSTIC ONCOLOGY CRO, Inc" on BioPortfolio

We have published hundreds of DIAGNOSTIC ONCOLOGY CRO, Inc news stories on BioPortfolio along with dozens of DIAGNOSTIC ONCOLOGY CRO, Inc Clinical Trials and PubMed Articles about DIAGNOSTIC ONCOLOGY CRO, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DIAGNOSTIC ONCOLOGY CRO, Inc Companies in our database. You can also find out about relevant DIAGNOSTIC ONCOLOGY CRO, Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record